MedTrace Logo

Automatically Transmitted Home Blood Pressure and Automated Patient Feedback in Hypertension Care: the AUTO 2 Trial

NCT07397260 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1304

Last updated 2026-05-12

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness of automatically-generated medical advice to patients about to their home blood pressure monitoring results sent through patient portal messages compared to no automated advice and the effectiveness of automated transmission of remotely-obtained blood pressure values compared to self-reported values on systolic blood pressure at 1-year follow up in patients with uncontrolled hypertension whose physicians or advance practice providers provide primary care at Northwestern Medicine. Persistence of effects through 18 months will also be assessed.

Conditions

  • Hypertension (HTN)

Interventions

OTHER

Self report of home measured blood pressure via patient EHR portal

Participants will be provided with a home blood pressure monitor and method to use the EHR portal to enter home collected blood pressures into the EHR.

OTHER

Automated feedback about home blood pressure results

Patients will received periodic messages about the results of their home blood pressure monitoring with suggestions to consult with clinical care team when indicated.

OTHER

Automated Transmission of Remotely Measured Blood Pressure

Participants will be provided with a blood pressure monitor and application to automatically transmit home blood pressures to their EHR record.

Sponsors & Collaborators

Principal Investigators

  • Stephen D Persell, MD,MPH · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-04
Primary Completion
2028-04-30
Completion
2028-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07397260 on ClinicalTrials.gov